Search for Clinical Trial Results

Sponsored By

Azotemia - 7 Studies Found

Status Study
Recruiting Study Name: Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
Condition: Haemolytic and Uremic Syndrome
Date: 2015-01-08
Interventions:
  • Drug: Azithromycin ZITHROMAX &
Completed Study Name: Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects
Condition:
  • Hemolytic-Uremic Syndrome
  • Children
  • Parents
  • Date: 2012-07-31
Recruiting Study Name: Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Date: 2016-09-08
Interventions: Biological: Extra blood draw samples
Recruiting Study Name: Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
Condition: Hemolytic Uremic Syndrome of Childhood
Date: 2014-07-28
Interventions:
  • Drug: Eculizumab

Terminated Study Name: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Condition: Hemolytic Uremic Syndrome
Date: 1999-10-18
Interventions:
  • Drug: SYNSORB Pk Other Name: O
Completed Study Name: Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Condition:
  • Hemolytic-uremic Syndrome
  • Escherichia Coli Infections

Date: 2011-07-28
Interventions: Other: HUS standard coverage care (including in ICU) HUS standard coverage care : plasmaphereses - eculi
Completed Study Name: Rituximab in Patients With Relapsed or Refractory TTP-HUS
Condition:
  • Thrombotic Thrombocytopenic Purpura
  • Hemolytic Uremic Syndrome

Date: 2007-09-17
Interventions: Drug: Rituximab Rituximab will be administered on weeks 1, 2, 3, and 4 at a dose of 375 mg/m2 per infusi